Abstract
Previous studies demonstrate that both membrane B7-H4 and B7-H4-Ig fusion protein could inhibit T-cell responses. In the present study, we explored the potential effect of B7-H4-Ig on liver injury in a hepatitis mouse model induced by concanavalin A (ConA). A B7-H4-Ig construct was introduced into animals by the hydrodynamic gene delivery approach. It was found that ectopic expression of B7-H4-Ig could inhibit ConA-induced elevation of serum levels of ALT and AST, suppress liver necrosis and even mortality of mice. Furthermore, we observed that pretreatment of B7-H4-Ig dramatically decreased serum levels and the expression of mRNA for IL-2, IFN-gamma and IL-4, but increased IL-10 in ConA-treated mice. Our results suggest that B7-H4-Ig may protect animals from liver injury induced by ConA, which could be associated with reduced serum levels for IL-2, IFN-gamma and IL-4 as well as enhanced IL-10 production.
(c) 2010 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alanine Transaminase / blood
-
Animals
-
Aspartate Aminotransferases / blood
-
B7-1 Antigen / blood
-
B7-1 Antigen / genetics
-
B7-1 Antigen / metabolism
-
B7-1 Antigen / therapeutic use*
-
Chemical and Drug Induced Liver Injury / blood
-
Chemical and Drug Induced Liver Injury / pathology
-
Chemical and Drug Induced Liver Injury / prevention & control*
-
Concanavalin A / pharmacology*
-
Gene Expression / drug effects
-
Gene Expression / genetics
-
Gene Transfer Techniques
-
Genetic Therapy / methods*
-
Humans
-
Immunoglobulin Fc Fragments / blood
-
Immunoglobulin Fc Fragments / genetics*
-
Immunoglobulin G / genetics*
-
Interferon-gamma / blood
-
Interferon-gamma / genetics
-
Interleukin-10 / blood
-
Interleukin-10 / genetics
-
Interleukin-2 / blood
-
Interleukin-2 / genetics
-
Interleukin-4 / blood
-
Interleukin-4 / genetics
-
Leukocytes, Mononuclear / metabolism
-
Liver / drug effects
-
Liver / metabolism
-
Liver / pathology
-
Mice
-
Mice, Inbred BALB C
-
Necrosis / chemically induced
-
Necrosis / pathology
-
Recombinant Fusion Proteins / blood
-
Recombinant Fusion Proteins / genetics
-
Recombinant Fusion Proteins / metabolism
-
Recombinant Fusion Proteins / therapeutic use*
-
Survival Analysis
-
V-Set Domain-Containing T-Cell Activation Inhibitor 1
Substances
-
B7-1 Antigen
-
Immunoglobulin Fc Fragments
-
Immunoglobulin G
-
Interleukin-2
-
Recombinant Fusion Proteins
-
V-Set Domain-Containing T-Cell Activation Inhibitor 1
-
Vtcn1 protein, mouse
-
Concanavalin A
-
Interleukin-10
-
Interleukin-4
-
Interferon-gamma
-
Aspartate Aminotransferases
-
Alanine Transaminase